Treating Severe Eosinophilic Asthma With an Autoinjector: A Patient’s Perspective

<p style="text-align: left;">NUCALA (mepolizumab) is for the add-on treatment of patients 6+ with severe eosinophilic asthma. Not for acute bronchospasm or status asthmaticus.</p> <p style="text-align: left;"><strong>Please See Important Safety Information Below</strong></p> <p>From spending time on the driving range to sitting at home instead of the waiting room, learn what the NUCALA Autoinjector can mean for your patients.</p> <p style="text-align: right;">MPLWCNT210111 October 2021<br />Produced in USA.</p>